Company / Total Assets
Ensysce Biosciences, Inc. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$7.5M
FY2025
5-year range
$2.7M / $7.5M
FY2022-FY2025
Trend
+33.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025 with a 3-year CAGR of +8.2%.
Improved from $3M to $7M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +8.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +8.2%, indicating consistent growth.
- In FY2025, total assets increased 33.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.5M | +33.1% |
| FY2024 | $5.6M | +106.7% |
| FY2023 | $2.7M | -54.0% |
| FY2022 | $5.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026